logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Recurrent ovarian cancer: rucaparib prolongs quality-adjusted survival

Patients receiving rucaparib had longer time without clinically relevant symptoms.